Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diphtheria toxoid + tetanus toxoid
- Development stage
- Unknown
- Lead developer
- Instituto Biológico Argentino
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Dite (formerly known as Vacuna Doble Adultos Biol) is an approved combination vaccine developed and manufactured by Instituto Biológico Argentino (BIOL). It is indicated for active immunization against diphtheria and tetanus in adults and children aged 7 years and older. The vaccine is formulated with purified diphtheria toxoid and tetanus toxoid adsorbed onto an aluminum hydroxide gel adjuvant. It is administered via intramuscular injection to provide active immunity by stimulating the production of neutralizing antibodies against diphtheria and tetanus toxins.
- Brand names
- DiteVacuna Doble Adultos Biol
- Other names
- diphtheria and tetanus toxoidsdiphtheria-tetanus vaccinedoble bacteriana adultos
02
Targets
TT (Tetanus toxoid)
Beyond the preview
Go deeper on diphtheria toxoid + tetanus toxoid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diphtheria toxoid + tetanus toxoid.